Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.
- NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_assertion description "[Targeted proteins, associated with different signal transduction pathways, have included transforming growth factor-alpha [TGF-alpha (MR(1))], its binding site the epidermal growth factor receptor [EGFR (MR(2))] sharing sequence homology to the breast cancer prognostic marker Her-2/neu, an apoptosis inhibiting protein [bcl-2 (MR(4))], and the androgen receptor [AR (MR(5))].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.
- NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_assertion evidence source_evidence_literature NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.
- NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_assertion SIO_000772 18686047 NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.
- NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_assertion wasDerivedFrom befree-2016 NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.
- NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_assertion wasGeneratedBy ECO_0000203 NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.
- befree-2016 importedOn "2016-02-19" NP686589.RAQvrNsHXN3A_6RHftC8FIyxuw0kII0rfRULc21wK662g130_provenance.